The DNA-encoded Library Market was valued at USD 758.1 million in 2024, and is projected to reach USD 1.60 billion by 2030, rising at a CAGR of 13.40%. The rising demand for novel and targeted drug discovery is one of the key factors driving the market growth. These libraries enable high-throughput screening of vast chemical compounds, significantly accelerating the identification of potential drug candidates. Traditional methods for screening chemical compounds can be time-consuming and resource-intensive, but DNA-encoded libraries streamline this process by attaching a unique DNA sequence to each compound, making it possible to rapidly identify and evaluate numerous candidates simultaneously. This efficiency is a major advantage in drug discovery, where speed and accuracy are critical.
Another significant factor propelling the growth of the DNA-encoded library industry is the increasing focus on precision medicine. As the healthcare industry moves toward more personalized treatments, the ability to discover drugs that specifically target individual genetic profiles becomes more valuable. DNA-encoded libraries offer a unique solution by enabling the creation of highly diverse libraries that can be tailored to target specific disease pathways or patient populations. This is particularly beneficial in the fields of oncology and genetic disorders, where personalized therapies have shown great promise in improving treatment outcomes.
The rising prevalence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, is also contributing to the market growth. The increasing burden of these diseases worldwide has spurred investments in drug discovery technologies that can lead to faster development of effective treatments. DNA-encoded libraries play a critical role in this by facilitating the discovery of novel small molecules, antibodies, and other biologics that can potentially address unmet medical needs. In particular, the growing interest in antibody-based therapies and immunotherapies has highlighted the importance of efficient drug discovery methods like DNA-encoded libraries.
Technological advancements in genomics and bioinformatics have further fueled the market's growth. As sequencing technologies have become more advanced and cost-effective, the ability to construct large, highly diverse DNA-encoded libraries has improved. The integration of bioinformatics tools has also enhanced the ability to analyze complex data, allowing researchers to optimize the selection of candidates and improve the efficiency of the drug discovery process. These advancements have made DNA-encoded libraries more accessible and effective, driving their adoption across pharmaceutical and biotechnology companies.
In addition, the increasing number of collaborations and partnerships between pharmaceutical companies, academic institutions, and contract research organizations is driving market expansion. These collaborations enable the sharing of resources and expertise, accelerating the development and application of DNA-encoded library technology in drug discovery. The market is also supported by increasing funding from both public and private sectors, as the potential for breakthrough drugs remains high. Together, these factors are creating a conducive environment for the growth and expansion of the DNA-encoded library market.
This product will be delivered within 1-3 business days.
Another significant factor propelling the growth of the DNA-encoded library industry is the increasing focus on precision medicine. As the healthcare industry moves toward more personalized treatments, the ability to discover drugs that specifically target individual genetic profiles becomes more valuable. DNA-encoded libraries offer a unique solution by enabling the creation of highly diverse libraries that can be tailored to target specific disease pathways or patient populations. This is particularly beneficial in the fields of oncology and genetic disorders, where personalized therapies have shown great promise in improving treatment outcomes.
The rising prevalence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, is also contributing to the market growth. The increasing burden of these diseases worldwide has spurred investments in drug discovery technologies that can lead to faster development of effective treatments. DNA-encoded libraries play a critical role in this by facilitating the discovery of novel small molecules, antibodies, and other biologics that can potentially address unmet medical needs. In particular, the growing interest in antibody-based therapies and immunotherapies has highlighted the importance of efficient drug discovery methods like DNA-encoded libraries.
Technological advancements in genomics and bioinformatics have further fueled the market's growth. As sequencing technologies have become more advanced and cost-effective, the ability to construct large, highly diverse DNA-encoded libraries has improved. The integration of bioinformatics tools has also enhanced the ability to analyze complex data, allowing researchers to optimize the selection of candidates and improve the efficiency of the drug discovery process. These advancements have made DNA-encoded libraries more accessible and effective, driving their adoption across pharmaceutical and biotechnology companies.
In addition, the increasing number of collaborations and partnerships between pharmaceutical companies, academic institutions, and contract research organizations is driving market expansion. These collaborations enable the sharing of resources and expertise, accelerating the development and application of DNA-encoded library technology in drug discovery. The market is also supported by increasing funding from both public and private sectors, as the potential for breakthrough drugs remains high. Together, these factors are creating a conducive environment for the growth and expansion of the DNA-encoded library market.
DNA-encoded Library Market Report Highlights
- The services segment led the DNA-encoded library industry, generating the highest revenue in 2024, driven by the increasing outsourcing of drug discovery research.
- Based on therapeutic area, the oncology segment held the largest revenue share of 38.32% in 2024, primarily due to the high demand for targeted cancer therapies.
- Based on application, the hit generation/identification segment dominated the market in 2024 with a share of 42.52%, due to the growing need for efficient lead discovery solutions.
- Based on end use, pharmaceutical and biotechnology companies accounted for the largest revenue share of 42.77% in 2024, primarily due to their extensive investment in drug discovery programs.
- North America is dominant in the market for DNA-encoded libraries, primarily due to its biotechnology sectors and robust pharmaceutical industry.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. DNA-Encoded Library Market Variables, Trends & Scope
Chapter 4. DNA-Encoded Library Market: Product & Service Estimates & Trend Analysis
Chapter 5. DNA-Encoded Library Market: Therapeutic Area Estimates & Trend Analysis
Chapter 6. DNA-Encoded Library Market: Application Estimates & Trend Analysis
Chapter 7. DNA-Encoded Library Market: End Use Estimates & Trend Analysis
Chapter 8. DNA-Encoded Library Market: Regional Estimates & Trend Analysis
Chapter 9. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies featured in this DNA-encoded Library market report include:- Merck KGaA
- GenScript
- Pharmaron
- WuXi Biology
- Aurigene Pharmaceutical Services
- BOC Sciences
- LGC Bioresearch Technologies
- SPT Labtech Ltd
- Life Chemicals
- Charles River Laboratories
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | May 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 758.1 Million |
| Forecasted Market Value ( USD | $ 1600 Million |
| Compound Annual Growth Rate | 13.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
